The optimal management of pancreatic cancer in elderly patients is undetermined. Elderly patients and patients of low socioeconomic status are, furthermore, underrepresented in clinical trials. For this study, researchers used Medicare and Surveillance, Epidemiology, and End Results (SEER) data to evaluate treatment trends, patient characteristics, and disease outcomes in this patient-group. Read more . . .
Elderly Medicare patients with low socioeconomic status are less likely receive pancreatic cancer treatment, according to a study published in The Oncologist.